Increasing frequency of opioid prescriptions for chronic abdominal pain in US outpatient clinics

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 12, 2011, Pages

  Dorn, Spencer D ^a   Meek, Patrick D ^b   Shah, Nilay D ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Chronic Abdominal Pain; Management; Opioid Analgesics

Indexed keywords

OPIATE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CHRONIC ABDOMINAL PAIN; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; OUTPATIENT DEPARTMENT; PRESCRIPTION; TREND STUDY; UNITED STATES;

EID: 82955187742     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.08.008     Document Type: Article

References (41)

1. Talley N.J., Zinsmeister A.R., Van Dyke C., et al. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991, 101:927-934.
2. Sandler R.S., Stewart W.F., Liberman J.N., et al. Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci 2000, 45:1166-1171.
3. Dorn S.D., Farley J.F., Hansen R.A., et al. Direct-to-consumer and physician promotion of Tegaserod correlated with physician visits, diagnoses, and prescriptions. Gastroenterology 2009, 137:518-524. 524.e1-2.
4. Sperber A.D., Drossman D.A. Functional abdominal pain syndrome: constant or frequently recurring abdominal pain. Am J Gastroenterol 2010, 105:770-774.
5. Kane R.L., Priester R., Totten A.M. Meeting the challenge of chronic illness 2005, Johns Hopkins University Press, Baltimore, MD.
6. Caudill-Slosberg M.A., Schwartz L.M., Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 2004, 109:514-519.
7. Olsen Y., Daumit G.L., Ford D.E. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain 2006, 7:225-235.
8. Cross R.K., Wilson K.T., Binion D.G. Narcotic use in patients with Crohn's disease. Am J Gastroenterol 2005, 100:2225-2229.
9. Dorn S.D., Morris C.B., Hu Y.J., et al. Patients with IBS commonly use narcotics. Gastroenterology 2010, 138:W1378.
10. Martell B.A., O'Connor P.G., Kerns R.D., et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007, 146:116-127.
11. Noble M., Treadwell J.R., Tregear S.J., et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010, CD006605.
12. Compton W.M., Volkow N.D. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend 2006, 83:S4-S7.
13. Paulozzi L.J., Budnitz D.S., Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006, 15:618-627.
14. Fishbain D.A., Cole B., Lewis J., et al. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors?. A structured evidence-based review. Pain Med 2008, 9:444-459.
15. Grunkemeier D.M., Cassara J.E., Dalton C.B., et al. The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clin Gastroenterol Hepatol 2007, 5:1126-1139.
16. Chang G., Chen L., Mao J. Opioid tolerance and hyperalgesia. Med Clin North Am 2007, 91:199-211.
17. Ambulatory health care data Centers for Disease Control and Prevention, Accessed December 12, 2010. http://www.cdc.gov/nchs/ahcd.htm.
18. Ambulatory health care data. Scope and sample design Centers for Disease Control and Prevention, Accessed December 12, 2010. http://www.cdc.gov/nchs/ahcd/ahcd_scope.htm.
19. Clinical Classifications Software (CCS) for ICD-9-CM Healthcare Cost and Utilization Project (HCUP), Accessed December 12, 2010. http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp.
20. Ambulatory health care data. The new ambulatory care drug database system Centers for Disease Control and Prevention, Accessed December 12, 2010. http://www2.cdc.gov/drugs/applicationnav1.asp.
21. Population estimates: Data sets for all geographies U.S. Census Bureau, Accessed March 17, 2011. http://www.census.gov/popest/datasets.html.
22. Baum C. An introduction to modern econometrics using stata 2006, Stata Corp, College Station, Texas.
23. Sullivan M.D., Edlund M.J., Fan M.Y., et al. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain 2008, 138:440-449.
24. Boudreau D., Von Korff M., Rutter C.M., et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 2009, 18:1166-1175.
25. McCaffery M., Pasero C.L. Pain ratings: the fifth vital sign. Am J Nurs 1997, 97:15-16.
26. Meier B. Narcotic maker guilty of deceit over marketing May 11 2007, New York Times, Accessed June 1, 2011. http://www.nytimes.com/2007/05/11/business/11drug.html.
27. Green C.R., Anderson K.O., Baker T.A., et al. The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med 2003, 4:277-294.
28. Anderson K.O., Green C.R., Payne R. Racial and ethnic disparities in pain: causes and consequences of unequal care. J Pain 2009, 10:1187-1204.
29. Staton L.J., Panda M., Chen I., et al. When race matters: disagreement in pain perception between patients and their physicians in primary care. J Natl Med Assoc 2007, 99:532-538.
30. Ballantyne J.C., Mao J. Opioid therapy for chronic pain. N Engl J Med 2003, 349:1943-1953.
31. Boscarino J.A., Rukstalis M., Hoffman S.N., et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction 2010, 105:1776-1782.
32. Sullivan M.D., Von Korff M., Banta-Green C., et al. Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain 2010, 149:345-353.
33. Fleming M.F., Balousek S.L., Klessig C.L., et al. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain 2007, 8:573-582.
34. Kunen S., Prejean C., Gladney B., et al. Disposition of emergency department patients with psychiatric comorbidity: results from the 2004 National Hospital Ambulatory Medical Care Survey. Emerg Med J 2006, 23:274-275.
35. De Schepper H.U., Cremonini F., Park M.I., et al. Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil 2004, 16:383-394.
36. Trescot A.M., Helm S., Hansen H., et al. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician 2008, 11:S5-S62.
37. Chou R., Fanciullo G.J., Fine P.G., et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009, 10:113-130.
38. VA/DoD Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain 2010, Management of Opioid Therapy for Chronic Pain Working Group, Veterans Health Administration, Department of Defense, Washington, DC.
39. Halder S.L., Locke G.R., Schleck C.D., et al. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 2007, 133:799-807.
40. Bhuiya F., Pitts S.R., McCaig L.F. Emergency department visits for chest pain and abdominal pain: United States, 1998-2008. NCHS data brief, no 43 2010, National Center for Health Statistics, Hyattsville, MD.
41. Reeves R.R., Carter O.S., Pinkofsky H.B., et al. Carisoprodol (soma): abuse potential and physician unawareness. J Addict Dis 1999, 18:51-56.